An overdose of Quillivant XR can lead to a variety of symptoms, including anxiety, restlessness, nausea, vomiting, tremors, and seizures. If you take too much of this medication, seek immediate medical attention.
Quillivant XR should be stored at room temperature, in its original container. Your pharmacist will mix the medication prior to dispensing it. The medication must be used within four months of being mixed.
Keep this and all other medications out of the reach of children. Because this medication is a controlled substance with the potential for abuse, you should keep it in a safe place.
What Should I Do If I Miss a Dose?
If you do not take your Quillivant XR as scheduled, take your missed dose as soon as you remember. If it is almost time for your next dose, however, skip the missed dose and continue with your regular schedule. Keep in mind that taking a dose later in the day may lead to difficulty with sleeping. Do not take a double dose.
Quillivant XR comes in one form and strength: Quillivant XR 25 mg per 5 mL. It is available in the following bottle sizes:
Quillivant XR contains extended-release methylphenidate. However, it is not the only available medication with this active ingredient. Methylphenidate extended-release is also available in tablet and capsule form. Other methylphenidate extended-release products include:
Some of the methylphenidate extended-release products are only approved to treat ADHD in children, while others (like Quillivant XR) can be used in children and adults. Also, some methylphenidate extended-release medicines are approved to treat narcolepsy in addition to attention deficit hyperactivity disorder.
Micromedex Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Reuters (Healthcare), Inc. Updated periodically. Accessed June 10, 2013.
Methylphenidate hydrochloride. Drug Facts and Comparisons. Drug Facts and Comparisons 4.0 [online]. 2013. Available from Wolters Kluwer Health, Inc. Accessed June 10, 2013.
Schoenstadt A. ADHD (June 25, 2008). eMedTV Web site. http://adhd.emedtv.com/adhd/adhd.html. Accessed June 10, 2013.
Quillivant XR Web site. Available at: www.quillivantxr.com. Accessed June 10, 2013.
Lexi-Interact [computer program]. Lexi-Comp, Inc.; July 10, 2013.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed June 10, 2013.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed June 10, 2013.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed June 10, 2013.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click